Mesoblast is committed to assisting patients and their healthcare professionals with obtaining access to Mesoblast’s investigational product candidates through clinical trial participation in the active development programs. A list of Mesoblast’s clinical trials may be accessed by clicking here or visiting clinical trial research portals such as:
- For trials being run in the United States: http://www.clinicaltrials.gov
- For trials being run in Australia and New Zealand: http://www.anzctr.org.au
- The World Health Organization (WHO) search portal for clinical trials: http://apps.who.int/trialsearch/
In certain circumstances, patients who do not qualify for clinical trials may seek access to Mesoblast’s investigational product candidates through Expanded Access. Mesoblast will evaluate each request on a case-by-case basis. If you are a patient with questions concerning access to Mesoblast’s investigational product candidates -- either through a clinical trial or through Expanded Access – please discuss your situation with your treating physician.
Healthcare professionals may send their request for Expanded Access to [email protected].